(MedPage Today) -- BERLIN - An investigational agent for type 2 diabetes was generally well tolerated in patients at high risk of heart disease, although data on specific cardiovascular outcomes have not yet been released, researchers reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment